<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31694409</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>03</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2167-9223</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1-2</Issue><PubDate><Year>2020</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</Title><ISOAbbreviation>Amyotroph Lateral Scler Frontotemporal Degener</ISOAbbreviation></Journal><ArticleTitle>A speech measure for early stratification of fast and slow progressors of bulbar amyotrophic lateral sclerosis: lip movement jitter.</ArticleTitle><Pagination><StartPage>34</StartPage><EndPage>41</EndPage><MedlinePgn>34-41</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/21678421.2019.1681454</ELocationID><Abstract><AbstractText><i>Objective</i>: To assess the utility of novel measures derived from a rapid syllable repetition task (i.e. oral dysdiadochokinesis [DDK]) in early stratification of fast and slow progressive bulbar amyotrophic lateral sclerosis (ALS) and prediction of bulbar disease progression rate. <i>Methods</i>: Fifty-four individuals with ALS were tracked longitudinally on their oral DDK and global bulbar/speech performance (i.e. bulbar subscore on the ALS Functional Rating Scale-Revised [ALSFRS-R]; articulation rate during passage reading) for a four-month average duration. Based on the bulbar deterioration rate over the tracked period, the participants were stratified as 14 fast bulbar progressors and 40 slow bulbar progressors using a posteriori classification approach. To determine if oral DDK performance predicts the differential bulbar disease progression trajectories in these individuals during the early stages of the tracked period (prior to significant bulbar/speech signs), twenty-two measures of lip motor performance in an oral DDK task were derived to (1) differentiate fast and slow bulbar progressors using the Receiver Operating Characteristic analysis and (2) predict bulbar disease progression rates across all individuals using linear regressions. <i>Results</i>: Movement jitter, a measure of temporal variability of alternating lip movement during DDK, showed 80% sensitivity and 95% specificity in differentiating fast and slow bulbar progressors early in the disease, and outperformed the ALSFRS-R bulbar subscore and articulation rate. Movement jitter also predicted bulbar disease progression rates across participants. <i>Conclusion</i>: Findings provided preliminary validation of the clinical value of movement jitter during oral DDK in patient stratification and bulbar disease prognosis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rong</LastName><ForeName>Panying</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-7067-0083</Identifier><AffiliationInfo><Affiliation>Department of Speech-Language-Hearing: Sciences &amp; Disorders, University of Kansas, Lawrence, KA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yunusova</LastName><ForeName>Yana</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Speech-Language Pathology, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eshghi</LastName><ForeName>Marziye</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Communication Sciences &amp; Disorders, MGH Institute of Health Professions, Boston, MA, USA, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rowe</LastName><ForeName>Hannah P</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Department of Communication Sciences &amp; Disorders, MGH Institute of Health Professions, Boston, MA, USA, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Green</LastName><ForeName>Jordan R</ForeName><Initials>JR</Initials><Identifier Source="ORCID">0000-0002-1464-1373</Identifier><AffiliationInfo><Affiliation>Department of Communication Sciences &amp; Disorders, MGH Institute of Health Professions, Boston, MA, USA, and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Speech and Hearing Biosciences and Technology Program, Harvard University, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K24 DC016312</GrantID><Acronym>DC</Acronym><Agency>NIDCD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DC009890</GrantID><Acronym>DC</Acronym><Agency>NIDCD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DC017291</GrantID><Acronym>DC</Acronym><Agency>NIDCD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>FRN126682</GrantID><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Amyotroph Lateral Scler Frontotemporal Degener</MedlineTA><NlmUniqueID>101587185</NlmUniqueID><ISSNLinking>2167-8421</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008046" MajorTopicYN="N">Lip</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009068" MajorTopicYN="N">Movement</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013060" MajorTopicYN="N">Speech</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bulbar amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">oral diadochokinesis</Keyword><Keyword MajorTopicYN="N">patient stratification</Keyword><Keyword MajorTopicYN="N">prognosis</Keyword></KeywordList><CoiStatement>Declaration of interest. The authors report no conflicts of interest. This work was supported by NIH-NIDCD under Grants R01DC009890, R01DC0135470, K24DC016312, the ALS Society of Canada under the Denise Ramsay Discovery Grant, and the CIHR Planning Grant no. FRN126682.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31694409</ArticleId><ArticleId IdType="mid">NIHMS1542811</ArticleId><ArticleId IdType="pmc">PMC7060806</ArticleId><ArticleId IdType="doi">10.1080/21678421.2019.1681454</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pattee GL, Plowman EK, Focht Garand KL, Costello J, Brooks BR, Berry JD, &#x2026; Green JR, Provisional best practices guidelines for the evaluation of bulbar dysfunction in amyotrophic lateral sclerosis. Muscle Nerve, 2019.</Citation><ArticleIdList><ArticleId IdType="pubmed">30620104</ArticleId></ArticleIdList></Reference><Reference><Citation>Green JR, Yunusova Y, Kuruvilla MS, Wang J, Pattee GL, Synhorst L, &#x2026; Berry JD, Bulbar and speech motor assessment in ALS: Challenges and future directions. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2013. 14(7&#x2013;8): p. 494&#x2013;500.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3833808</ArticleId><ArticleId IdType="pubmed">23898888</ArticleId></ArticleIdList></Reference><Reference><Citation>Yunusova Y, Plowman EK, Green JR, Barnett C, and Bede P, Clinical Measures of Bulbar Dysfunction in ALS. Frontiers in neurology, 2019. 10: p. 106&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6389633</ArticleId><ArticleId IdType="pubmed">30837936</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry BJ, Martino R, Yunusova Y, Plowman EK, and Green JR, Lingual and Jaw Kinematic Abnormalities Precede Speech and Swallowing Impairments in ALS. Dysphagia, 2018. 33(6): p. 840&#x2013;847.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6244810</ArticleId><ArticleId IdType="pubmed">29774424</ArticleId></ArticleIdList></Reference><Reference><Citation>Zemlin WR, Speech and Hearing Science: Anatomy and Physiology. 4th ed. 1998: Pearson.</Citation></Reference><Reference><Citation>Rong P, Yunusova Y, Wang J, and Green JR, Predicting early bulbar decline in Amyotrophic Lateral Sclerosis: a speech subsystem approach. Behavioural Neurology, 2015. 2015: p. 183027.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4468279</ArticleId><ArticleId IdType="pubmed">26136624</ArticleId></ArticleIdList></Reference><Reference><Citation>Rong PY, Yunusova Y, Wang J, Zinman L, Pattee GL, Berry JD, &#x2026; Green JR, Predicting Speech Intelligibility Decline in Amyotrophic Lateral Sclerosis Based on the Deterioration of Individual Speech Subsystems. Plos One, 2016. 11(5).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4858181</ArticleId><ArticleId IdType="pubmed">27148967</ArticleId></ArticleIdList></Reference><Reference><Citation>Rong P, Yunusova Y, Richburg B, and Green JR, Automatic extraction of abnormal lip movement features from the alternating motion rate task in amyotrophic lateral sclerosis. International Journal of Speech-Language Pathology, 2018. September 25: p. 1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6449219</ArticleId><ArticleId IdType="pubmed">30253671</ArticleId></ArticleIdList></Reference><Reference><Citation>Rong P, Yunusova Y, and Green JR. Speech intelligibility decline in individuals with fast and slow rates of ALS progression. in Interspeech 2015. Dresden, Germany: Proceedings of Interspeech.</Citation></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, and Nakanishi A, The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). Journal of Neurological Sciences, 1999. 169(1&#x2013;2): p. 13&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Yunusova Y, Graham NL, Shellikeri S, Phuong K, Kulkarni M, Rochon E, &#x2026; Green JR, Profiling Speech and Pausing in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Plos One, 2016. 11(1).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4720472</ArticleId><ArticleId IdType="pubmed">26789001</ArticleId></ArticleIdList></Reference><Reference><Citation>Ball L, Beukelman D, and Pattee GL, Timing of speech deterioration in people with amyotrophic lateral sclerosis. Vol 10 2002. 231&#x2013;235.</Citation></Reference><Reference><Citation>Yorkston KM, Strand EA, Miller R, and Smith K, Speech deterioration in amyotrophic lateral sclerosis: Implications for the timing of intervention. Journal of Medical Speech-Language Pathology, 1993. 1(1): p. 35&#x2013;46.</Citation></Reference><Reference><Citation>Stergiou N and Decker LM, Human movement variability, nonlinear dynamics, and pathology: is there a connection? Human movement science, 2011. 30(5): p. 869&#x2013;888.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3183280</ArticleId><ArticleId IdType="pubmed">21802756</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon NG, Turner MR, Vucic S, Al-Chalabi A, Shefner J, Lomen-Hoerth C, and Kiernan MC, Quantifying disease progression in amyotrophic lateral sclerosis. Annals of neurology, 2014. 76(5): p. 643&#x2013;657.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4305209</ArticleId><ArticleId IdType="pubmed">25223628</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura F, Fujimura C, Ishida S, Nakajima H, Furutama D, Uehara H, &#x2026; Hanafusa T, Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology, 2006. 66(2): p. 265&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">16434671</ArticleId></ArticleIdList></Reference><Reference><Citation>Kollewe K, Mauss U, Krampfl K, Petri S, Dengler R, and Mohammadi B, ALSFRS-R score and its ratio: a useful predictor for ALS-progression. J Neurol Sci, 2008. 275(1&#x2013;2): p. 69&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">18721928</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>